Innate Pharma SA Vs. Genfit SA Industry Stock Comparison

Sell

27

IPHA
Innate Pharma SA

Last Price:

1.58

Seasonality Move:

6.04%

Sell

18

GNFT
Genfit SA

Last Price:

4.21

Seasonality Move:

16.07%

Sell

27

Innate Pharma SA (IPHA) is a Sell

Is Innate Pharma SA a Buy, Sell or Hold?

The current Innate Pharma SA [IPHA] share price is $1.63. The Score for IPHA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
IPHA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

18

Genfit SA (GNFT) is a Sell

Is Genfit SA a Buy, Sell or Hold?

The current Genfit SA [GNFT] share price is $4.20. The Score for GNFT is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
GNFT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

IPHA Stock Price Chart

What is Innate Pharma SA's stock price today?

The Innate Pharma SA share price today is $1.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing slight buying pressure.

GNFT Stock Price Chart

What is Genfit SA's stock price today?

The Genfit SA share price today is $4.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GNFT is experiencing selling pressure, which indicates risk of future bearish movement.

IPHA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.1	Sell
Relative Strength Index (14 RSI):	42.81	Sell
Chaikin Money Flow:	999	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.64 - 1.92)	Sell
Bollinger Bands (100):	(1.88 - 2.3)	Sell

GNFT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.34	Sell
Relative Strength Index (14 RSI):	25.91	Sell
Chaikin Money Flow:	-3064	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(4.65 - 5.87)	Sell
Bollinger Bands (100):	(4.05 - 5.45)	Sell

IPHA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.6	Buy
20-day SMA:	1.75	Sell
50-day SMA:	1.97	Sell
200-day SMA:	2.3	Sell
8-day EMA:	1.65	Sell
20-day EMA:	1.74	Sell
50-day EMA:	1.91	Sell
200-day EMA:	2.24	Sell

GNFT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	4.45	Sell
20-day SMA:	5.14	Sell
50-day SMA:	5.27	Sell
200-day SMA:	4.32	Sell
8-day EMA:	4.48	Sell
20-day EMA:	4.92	Sell
50-day EMA:	5.06	Sell
200-day EMA:	4.5	Sell

Innate Pharma SA Earnings Growth & IPHA Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.

Genfit SA Earnings Growth & GNFT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.85 per share, and a decrease next year of $1.47 per share.

Innate Pharma SA Technical Analysis

	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22
	Nov
	11	12	13	14	15	18	19	20	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Genfit SA Technical Analysis

	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22
	Nov
	11	12	13	14	15	18	19	20	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):